Medicine and Dentistry
Hepatectomy
100%
Surgery
84%
Gastric Bypass Surgery
71%
Neoplasm
69%
Surgical Anastomosis
66%
Gastric Bypass
62%
Myeloid Cell
52%
Bariatric Surgery
51%
Pancreaticoduodenectomy
44%
Endoscopic Retrograde Cholangiopancreatography
43%
Colorectal Liver Metastasis
36%
Gastric Banding
34%
Postoperative Complication
33%
Diabetes
32%
Laparoscopic Sleeve Gastrectomy
32%
Common Bile Duct Stone
32%
Long Term Survival
32%
Pancreas Adenocarcinoma
32%
Syringomyelia
32%
Kidney Transplantation
32%
Myeloid-Derived Suppressor Cell
32%
Body Mass Index
29%
Malignant Neoplasm
27%
Reoperation
24%
Diabetes Mellitus
22%
Cholangiocarcinoma
20%
Sleeve Gastrectomy
20%
Echography
20%
Pancreatic Surgery
20%
Learning Curve
19%
Ependymoma
18%
Inferior Vena Cava
17%
Distal Pancreatectomy
17%
Splenectomy
17%
Health Care Cost
17%
Adenocarcinoma
17%
Pancreatectomy
17%
Systematic Review
16%
Biopsy
16%
Serositis
16%
Meta-Analysis
16%
Metastatic Colorectal Cancer
16%
Amylase
16%
Stomach
16%
Ileostomy
16%
Neuromonitoring
16%
Elderly Patient
16%
Mitochondrial DNA
16%
Peroperative Echography
16%
Abdominal Wall Hernia
16%
Keyphrases
Runt-related Transcription Factor 1 (RUNX1)
97%
Immature Myeloid Cells
65%
One-anastomosis Gastric Bypass
65%
Angiogenic
51%
Tertiary Care Hospital
48%
Pancreaticoduodenectomy
46%
Tumor
41%
Colorectal Liver Metastases
38%
Liver Resection
35%
Endoscopic Retrograde Cholangiopancreatography
34%
Bariatric Surgery
34%
Laparoscopic Adjustable Gastric Banding
32%
Myeloid-derived Suppressor Cells
32%
Laparoscopic Sleeve Gastrectomy
32%
Syringomyelia
32%
Murine Model
32%
Anatomic Liver Resection
32%
Open Liver Resection
32%
Laparoscopic Liver Resection
32%
Laparoscopic versus Open
32%
Long-term Survival
32%
Postoperative Complications
30%
Dendritic Cells
29%
Resection
27%
CD11b+
26%
Retrospective Analysis
25%
Readmission
25%
Reoperation
23%
Postoperative Course
22%
Tumor Growth
22%
Length of Hospital Stay
22%
Sleeve Gastrectomy
21%
After Surgery
21%
Angiogenesis
21%
Megakaryocytic
20%
Morbidity Mortality
20%
Surgical Treatment
20%
Pancreatic Surgery
20%
Single Center
19%
Diabetic
19%
Ly6G
19%
Transcriptional Signature
19%
Intrahepatic Cholangiocarcinoma (iCCA)
19%
Mouse Model
19%
Acute Myeloid Leukemia
19%
Learning Curve
19%
Kidney Transplantation
19%
Tumor Progression
18%
Diabetes
18%
Early Reoperation
18%